Kristen Alexander
VP, Finance and Accounting, Lexicon Pharmaceuticals.
Companies
- Lexicon PharmaceuticalsVP, Finance and Accounting Sep 27, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Lexicon Pharmaceuticals LXRX76,368 shares2$119.5K at $1.56Feb 28, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2025Shares withheld for tax 17,862 shares at $0.67 of Lexicon Pharmaceuticals2
- Feb 28, 2025Exercised options 19,887 shares of Lexicon Pharmaceuticals2
- Feb 28, 2025Exercised options 15,926 shares of Lexicon Pharmaceuticals2
- Feb 28, 2025Exercised options 10,617 shares of Lexicon Pharmaceuticals2
- Feb 28, 2024Shares withheld for tax 11,793 shares at $2.62 of Lexicon Pharmaceuticals3
- Feb 28, 2024Exercised options 15,927 shares of Lexicon Pharmaceuticals3
- Feb 28, 2024Exercised options 10,616 shares of Lexicon Pharmaceuticals3
- Feb 28, 2024Exercised options 2,700 shares of Lexicon Pharmaceuticals3
- Feb 28, 2023Shares withheld for tax 5,330 shares at $2.17 of Lexicon Pharmaceuticals4
- Feb 28, 2023Exercised options 10,617 shares of Lexicon Pharmaceuticals4
- Feb 28, 2023Exercised options 2,700 shares of Lexicon Pharmaceuticals4
- Feb 28, 2023Exercised options 5,400 shares of Lexicon Pharmaceuticals4
- Feb 28, 2022Shares withheld for tax 3,337 shares at $2.85 of Lexicon Pharmaceuticals5
- Feb 28, 2022Exercised options 2,700 shares of Lexicon Pharmaceuticals5
- Feb 28, 2022Exercised options 5,400 shares of Lexicon Pharmaceuticals5
- Feb 28, 2022Exercised options 3,200 shares of Lexicon Pharmaceuticals5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 29, 2024
- 4SEC EDGARForm 4 filed Mar 1, 2023
- 5SEC EDGARForm 4 filed Feb 28, 2022